Pharma industry risks product integrity and profits with wrong bookings and squeezing suppliers
Logistics companies have warned the pharmaceutical industry it risks major losses by failing to send temperature-sensitive medicines by the correct service.
While airlines have invested heavily in the past few years on expedited and temperature-controlled services, pharma companies continue to try to cut costs by shipping their products as general air cargo.
“There is a common perception among pharmaceutical manufacturers that they can still stick on a temperature label, or add an instruction to the air waybill and presume it will be shipped accordingly,” Mark Edwards, managing director of Modalis, told delegates at last week’s Cold Chain Distribution event in London.
Source: The Loadstar
